Public trial registry of the CCC-Munich

Trial ACCEPT

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
ACCEPT
World
Full title
:

Gemcitabin in Kombination mit dem oralen irreversiblen ErbB-Inhibitor Afatinib im Vergleich zu Gemcitabin allein bei Patienten mit metastasiertem Pankreaskarzinom: eine explorative randomisierte Phase-II-Studie

World
Description
:
Unknown
Eye
Primary endpoints
:

Eye
Secondary endpoints
:

World
EudraCT number
:
World
DRKS number
:
Unknown
World
NCT number
:
Unknown
World
ISRCTN number
:
Unknown
World
Responsible organization
:
Medizinische Klinik III, Telefon: 089440072551
Eye
Legal basis
:
AMG interventional
Eye
Registered by
:
MUELLER-MA15 ()
Indications
Classification Code Description
ICD-10-GM C25.- Bösartige Neubildung des Pankreas
- Pancreas carcinoma
In-/Exclusion (Edit)
Eye
Criterion for Inclusion
:
Unknown
Eye
Criterion for exclusion
:
Unknown
Trial design
World
IIT (sponsored by KUM)
:
Yes, Sponsor acquisition date:
Eye
Sponsor status
:
Unknown
World
Trial type
:
Interventional
World
Blinding type
:
Open
World
Phase
:
II
Eye
Center design
:
Polycentric
Eye
Treatment arms count
:
Unknown
Eye
Sample size
:
0
Status
World
Status
:
Recruitment active
Votes
World
Institutional review board - vote
:
Unknown
World
Institutional review board - reference number
:
World
PEI - vote
:
Unknown
World
PEI - reference number
:
World
BfArM - vote
:
Unknown
World
BfArM - reference number
:
Initiiation & lock
World
Date of lock (planned / actual)
:
2015-07-01 / Unknown
Recruitment
Eye
Time period (from / to)
:
Unknown / Unknown
Therapy
World
Therapy line
:
1
Eye
Therapy Category
:
World
Therapy
:

Tumorboards (Edit)
Eye
:
Dermatology Endocrinology Gastrointestinal
Gynecological Hematology KHT
Liver Lung Neurooncological
Pediatry Ortho. / Sarkoma Urological
Additionally involved centers (Edit)
Eye
:
Pharmacy Radiology
Institut für Labormedzin Transfusiology
Radiotherapy Nuclear medicine
Participants
Function Prename Surname Organization
World Principal Investigator VOLKER HEINEMANN Keine Organisationseinheit angegeben Magnifier